Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2020. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 142541000087111 | Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 142551000087114 | Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 142561000087112 | Inf LAIV4 tetravalent live attenauted intranasal Influenza A H1N1 and H3N2 and Influenza B Victoria and Yamagata vaccine product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | est un(e) (attribut) | Vaccine product containing only influenza A virus subtypes H1N1 and H3N2 and influenza B virus Victoria and Yamagata lineage antigens (medicinal product) | true | Inferred relationship | Some | ||
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | a pour principe actif (attribut) | Antigen of live attenuated Influenza A virus subtype H1N1 (substance) | true | Inferred relationship | Some | 1 | |
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | a pour principe actif (attribut) | Antigen of live attenuated Influenza B virus Victoria lineage (substance) | true | Inferred relationship | Some | 4 | |
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | est un(e) (attribut) | Influenza virus antigen only vaccine product in nasal dose form | true | Inferred relationship | Some | ||
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | est un(e) (attribut) | Vaccine product containing only live attenuated Influenza virus antigen (medicinal product) | false | Inferred relationship | Some | ||
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | a pour principe actif (attribut) | Live attenuated Influenza A virus subtype H3N2 antigen | true | Inferred relationship | Some | 2 | |
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | Count of active ingredient | quatre | false | Inferred relationship | Some | ||
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage nasal (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | a pour principe actif (attribut) | Antigen of live attenuated Influenza B virus Yamagata lineage (substance) | true | Inferred relationship | Some | 3 | |
| Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | est un(e) (attribut) | Vaccine product containing only live attenuated Influenza virus antigen (medicinal product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) | est un(e) (attribut) | True | Vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage live attenuated antigens in nasal dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR